Meglumine antimoniate
Sponsors
Fundación Cardiovascular de Colombia, University of Brasilia, Combined Military Hospital, Pakistan, Centro Internacional de Entrenamiento e Investigaciones Médicas, Hospital Universitário Professor Edgard Santos
Conditions
Cutaneous LeishmaniasesCutaneous LeishmaniasisCutaneous LeishminiasisLeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; AmericanLocalized Cutaneous LeishmaniasisMucocutaneous Leishmaniasis
Phase 2
Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous Leishmaniasis
CompletedNCT00973128
Start: 2004-02-29End: 2007-05-31Updated: 2009-09-09
Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
CompletedNCT01301924
Start: 2008-10-31End: 2017-12-31Updated: 2018-05-15
Low Antimonial Dosage in American Mucosal Leishmaniasis
NCT01301937
Start: 2008-10-31End: 2021-12-31Target: 76Updated: 2018-07-12
The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
Active, not recruitingNCT02530697
Start: 2015-08-31End: 2026-08-31Target: 160Updated: 2024-01-16
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
CompletedNCT03294161
Start: 2014-12-31End: 2017-06-30Updated: 2017-09-26
Comparison of Intralesional Glucantime With and Without Fractional CO₂ Laser in Adults With Cutaneous Leishmaniasis
Not yet recruitingNCT07652021
Start: 2026-08-01End: 2027-06-30Target: 150Updated: 2026-06-18
Phase 3
Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
TerminatedNCT00317629
Start: 2006-05-31End: 2009-03-31Updated: 2010-11-24
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
NCT00487253
Start: 2007-07-31End: 2010-12-31Target: 150Updated: 2010-02-17
High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
TerminatedNCT01953744
Start: 2014-02-28End: 2015-11-30Updated: 2015-12-02
Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)
CompletedNCT04340128
Start: 2007-05-31End: 2007-12-31Updated: 2020-04-09
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
CompletedNCT04515186
Start: 2021-01-26End: 2024-02-27Updated: 2025-05-08
Phase 4
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
CompletedNCT00317980
Start: 2006-02-28End: 2008-12-31Updated: 2009-01-22
Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients
CompletedNCT00818818
Start: 2008-08-31End: 2010-04-30Updated: 2010-10-08
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
CompletedNCT01032187
Start: 2007-10-31End: 2010-07-31Updated: 2017-09-05